The adipocyte: A model for integration of endocrine and metabolic signaling in energy metabolism regulation

American Journal of Physiology - Endocrinology and Metabolism

Volumn 280, Issue 6 43-6, 2001, Pages

  Frühbeck, Gema ^a,b   Gómez Ambrosi, Javier ^b   Muruzábal, Francisco José ^b   Burrell, María Angela ^b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Insulin resistance; Interleukins; Leptin; Obesity; Tumor necrosis factor

Indexed keywords

ADIPSIN; CYTOKINE; INTERLEUKIN 6; LEPTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; COMBUSTION; CYTOKINE RELEASE; ENERGY METABOLISM; ENERGY RESOURCE; HOMEOSTASIS; HUMAN; HUMAN CELL; INSULIN RESISTANCE; METABOLIC REGULATION; OBESITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0034987715     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.2001.280.6.e827     Document Type: Review

References (198)

1. Leptin
2. Development of white adipose tissue
3. A nitric oxide-mediated mechanism regulates lipolysis in human adipose tissue in vivo
4. Hormones and body composition in humans: Clinical studies
5. Relationship of plasma leptin to plasma cytokines and human survival in sepsis and septic shock
6. Regulation of metabolism and body fat mass by leptin
7. Activation of downstream signals by the long form of the leptin receptor
8. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors
9. Role of cytokines in the regulation of plasminogen activator inhibitor-1 expression and secretion in newly differentiated subcutaneous human adipocytes
10. The role of SOCS-3 in leptin signaling and leptin resistance
11. Divergent signaling capacities of the long and short isoforms of the leptin receptor
12. The regulation of adipose tissue distribution in humans
13. The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes
14. The adipose conversion process: Regulation by extracellular and intracellular factors
15. Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: Leptin inhibits cortisol release directly
16. Plasma cytokine and endotoxin levels correlate with survival in patients with sepsis
17. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin
18. Influence of thyroxine in vivo on preadipocyte development and insulin-like growth factor-I and IGF binding protein secretion in fetal stromal vascular cell cultures
19. Adipsin and an endogenous pathway of complement from adipose cells
20. Novel B219/OB receptor isoforms: Possible role of leptin in hematopoiesis and reproduction
21. A developmentally regulated mRNA from 3T3 adipocytes encodes a novel serine protease homologue
22. Regulation of adipocyte development
23. Hyperleptinemia is more closely associated with adipose cell hypertrophy than with adipose tissue hyperplasia
24. Differentiation of preadipose cells: Paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-II
25. Plasma plasminogen activator inhibitor-1 is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women
26. Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor γ
27. Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: Evidence for sex- and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor gamma2
28. A new class of obesity genes encodes leukocyte adhesion receptors
29. Glucagon-like peptides
30. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass
31. Effects of an intravenous injection of NPY on leptin and NPY-Y1 receptor mRNA expression in ovine adipose tissue
32. Insulin resistance: An adaptation for weight maintenance
33. Taming TNF: Strategies to restrain this proinflammatory cytokine
34. Cloning and functional expression of a thyrotropin receptor cDNA from rat fat cells
35. Tumor necrosis factor alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates
36. Tumor necrosis factor (TNF)-α induces leptin production through the p55 TNF receptor
37. The adipocyte: Storage depot or node on the energy information superhighway?
38. Fuel selection in white adipose tissue
39. Regulation of fatty acid movement in human adipose tissue in the postabsorptive-to-postprandial transition
40. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid
41. Diverse roles of adipose tissue in the regulation of systemic metabolism and energy balance
42. Pivotal role of nitric oxide in the control of blood pressure following leptin administration
43. In vitro lipolytic effect of leptin on mouse adipocytes: Evidence for a possible autocrine/paracrine role of leptin
44. Leptin: Physiology and pathophysiology
45. Free insulin-like growth factors in human obesity
46. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells
47. Effects of palatable diets on body weight and adipose tissue cellularity in the adult obese female Zueker rat (fa/fa)
48. Modulation of white adipose tissue lipolysis by nitric oxide
49. Coordinating regulation of triacylglycerol synthesis and glucose transport by acylation stimulating protein
50. Depot-specific release of leptin from subcutaneous and omental adipocytes in suspension culture: Effect of tumor necrosis factor-α and transforming growth factor-β1
51. Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: A possible role for interleukin 6 in cancer cachexia
52. Tumor necrosis factor (TNF) receptors in cellular signaling of soluble and membrane-expressed TNF
53. The metabolic effects of tumor necrosis factor and other cytokines
54. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters
55. Plasma concentrations of TNF-α and its soluble receptors in obese subjects
56. Effects of tumour necrosis factor alpha (TNF) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture
57. Effects of epidermal growth factor (EGF), platelet-derived growth factor (PDGF) and fibroblast growth factor (FGF) on human adipocyte development and function
58. Soluble hormone receptors
59. Adipophilin is a specific marker of lipid accumulation in diverse cell types and diseases
60. Adipose tissue cellularity in human obesity
61. Differential regulation of the p80 of tumor necrosis factor receptor in human obesity and insulin resistance
62. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance
63. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein
64. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance
65. Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance
66. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients
67. AdipoQ is a novel adipose-specific gene dysregulated in obesity
68. Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: Role of obesity and non-insulin-dependent diabetes mellitus
69. The role of TNF-α in human adipose tissue: Prevention of weight gain at the expense of insulin resistance?
70. The phosphodiesterase inhibitor IBMX suppresses TNF-α expression in human adipocyte precursor cells: A possible explanation for its adipogenic effect
71. Jaks and Stats in signaling by the cytokine receptor superfamily
72. Cytokines and endocrine function: An interaction between the immune and neuroendocrine systems
73. Identification and characterization of the glucagon receptor from adipose tissue
74. Interleukin 1α increases serum leptin concentrations in humans
75. Lipolysis: Contribution from regional fat
76. Angiotensinogen gene expression in adipose tissue: Analysis of obese models and hormonal and nutritional control
77. The soluble interleukin 6 receptor: Mechanisms of production and implications in disease
78. PAI-1, obesity, insulin resistance and risk of cardiovascular events
79. Vitamin D receptor gene expression is up-regulated by 1,25-dihydroxyvitamin D3 in 3T3-L1 preadipocytes
80. Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1
81. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase
82. The adipoinsular axis: Effects of leptin on pancreatic β-cells
83. Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle
84. In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: Overlapping but distinct pathways from insulin
85. Tumor necrosis factor α contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes
86. Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes and yellow fur
87. Effects of obesity on fat topography: Metabolic and endocrine determinants
88. Low-density lipoprotein receptors in rat adipocytes: Regulation with fasting
89. Tumor necrosis factor-α stimulates cell proliferation in adipose tissue-derived stromal-vascular cell culture: Promotion of adipose tissue expansion by paracrine growth factors
90. Tumor necrosis factor-α- and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling
91. Fat cell adrenergic receptors and the control of white and brown fat cell function
92. Update on thyroid releasing hormone
93. Abnormal splicing of the leptin receptor in diabetic mice
94. Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction
95. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function
96. Tumor necrosis factor-α acutely inhibits insulin signaling in human adipocytes. Implication of the p80 tumor necrosis factor receptor
97. Detection and quantification of the leptin receptor splice variants Ob-Ra, b, and e in different mouse tissues
98. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression
99. PPARγ: An essential regulator of adipogenesis and modulator of fat cell function
100. In vivo and in vitro ob gene expression and leptin secretion in rat adipocytes: Evidence for a regional specific regulation by sex steroid hormones
101. Threading analysis suggests that the obese gene product may be a helical cytokine
102. Mechanisms for the pleiotropic effects of the agouti gene
103. The role of leptin in human obesity and disease: A review of current evidence
104. Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans
105. Insulin-like growth factor I mediates high-fat diet-induced adipogenesis in Osborne-Mendel rats
106. Acute in vitro production of acylation stimulating protein in differentiated human adipocytes
107. Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women
108. Induction by cytokines of the pattern of pituitary hormone secretion in infection
109. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo
110. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo
111. Adipose tissue as an endocrine and paracrine organ
112. Depot- and sex-specific differences in human leptin mRNA expression. Implications for the control of regional fat distribution
113. High fat diets elevate tissue-derived tumor necrosis factor-α activity
114. Overlapping and distinct signals through leptin receptor (OB-R) and a closely related cytokine signal transducer, gp130
115. Differential effects of fibroblast growth factor and tumor promoters on the initiation and maintenance of adipocyte differentiation
116. Interleukin-6 stimulates hepatic triglyceride secretion in rats
117. Identification of progesterone receptor in human subcutaneous adipose tissue
118. Effects of an engineered human anti-TNF-α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM
119. Exercise stimulates interleukin-6 secretion: Inhibition by glucocorticoids and correlation with catecholamines
120. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced thyrosine phosphorylation
121. Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphyngomyelinase
122. Tumor necrosis factor-alpha prevents the differentiation of human adipocyte precursor cells and causes delipidation of newly developed fat cells
123. Circulating tumor necrosis factor α is elevated in male but not in female patients with type II diabetes mellitus
124. Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes
125. Effect of isoprenaline on plasma leptin and lipolysis in humans
126. Cytokines and endothelial cell biology
127. Impaired postprandial clearance of triacylglycerol-rich lipoproteins in adipose tissue in obese subjects
128. Tumor necrosis factor-α induces apoptosis of human adipose cells
129. Fat cells
130. 2 to suppress pulsatile release of luteinizing hormone but not follicle stimulating hormone
131. White adipose tissue nitric oxide synthase: A potential source for NO production
132. Human adipose tissue glycogen levels and responses to carbohydrate feeding
133. Preparation of soluble murine IL-6 receptor and anti-murine IL-6 receptor antibodies
134. Regulation of macrophage migration inhibitory factor (MIF) expression by glucose and insulin in adipocytes in vitro
135. Regional variation in high-density lipoprotein binding to human adipocyte plasma membranes of massively obese subjects
136. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice
137. Elevated expression of transforming growth factor-β in adipose tissue from obese mice
138. Multiple cytokines and acute inflammation raise mouse leptin levels: Potential role in inflammatory anorexia
139. Fasting inhibits natriuretic peptides clearance receptor expression in rat adipose tissue
140. A novel serum protein similar to C1q, produced exclusively in adipocytes
141. Adipose conversion of 3T3-L1 cells in a serum-free culture system depends on epidermal growth factor, insulin-like growth factor I, corticosterone, and cyclic AMP
142. Obesity and diabetes in TNF-α receptor-deficient mice
143. Endocrine and paracrine negative regulators of adipose differentiation
144. -/-) mice after short-term high-fat feeding
145. Direct antidiabetic effect of leptin through triglyceride depletion of tissues
146. Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity
147. Biological action of leptin as an angiogenic factor
148. The adipsin-ASP pathway and regulation of adipocyte function
149. Levels of acylation stimulating protein in obese women before and after moderate weight loss
150. Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women
151. Adipogenesis and obesity: Rounding out the big picture
152. Control of specific protein biosynthesis during the adipose conversion of 3T3 cells
153. Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes
154. Some recent advances in the chemistry and biology of transforming growth factor-β
155. Tumor necrosis factor-α-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction
156. Transcriptional repression of Glut-4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor alpha
157. Recombinant soluble human interleukin-6 receptor. Expression in Escherichia coli, renaturation and purification
158. Evidence for the involvement of interleukin 6 in experimental cancer cachexia
159. Selective interaction between leptin and insulin signaling pathways in a hepatic cell line
160. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
161. The leptin receptor
162. Comparison of receptors for insulin-like growth factor II from various rat tissues
163. Mouse very low-density lipoprotein receptor (VLDLR): Gene structure, tissue-specific expression and dietary and developmental regulation
164. 1B-adrenoceptors
165. A macrophage factor inhibits adipocyte gene expression: An in vitro model of cachexia
166. New insights into the development of obesity: Obese genes and the leptin system
167. Dose effects of recombinant interleukin-6 on pituitary hormone secretion and energy expenditure
168. Functional analysis of tumor necrosis factor (TNF) receptors in TNF-α-mediated insulin resistance in genetic obesity
169. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function
170. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects
171. The association of human adipose angiotensinogen gene expression with abdominal fat distribution in obesity
172. Interleukin-6: An overview
173. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo
174. Differential expression of adenosine A1 and A2 receptors in preadipocytes and adipocytes
175. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity
176. Expression and regulation of growth hormone (GH) receptor messenger ribonucleic acid (mRNA) in rat adipose tissue, adipocytes, and adipocyte precursor cells: GH regulation of GH receptor mRNA
177. Retinoids and adipose tissues: Metabolism, cell differentiation and gene expression
178. The role of growth hormone/insulin growth factors in adipocyte differentiation
179. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat
180. Novel form of lipolysis induced by leptin
181. Hyperleptinemia depletes fat from denervated fat tissue
182. Inactivation of tissue plasminogen activator in plasma: Demonstration of a complex with a new rapid inhibitor
183. Mechanism of fluorescent fatty acid transfer from adipocyte fatty acid binding protein to membranes
184. TNF alpha-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPAR gamma without effects on Pref-1 expression
185. Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue
186. Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL-6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130
187. Functional GIP receptors are present on adipocytes
188. GIP biology and fat metabolism
189. Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link?
190. Glucocorticoids as counterregulatory hormones of leptin: Toward an understanding of leptin resistance
191. Agouti regulation of intracellular calcium: Role in insulin resistance of viable yellow mice
192. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-α
193. Crystal structure of the obese protein leptin-E100
194. Tumour necrosis factor-α exerts dual effects on human adipose leptin synthesis and release
195. The leptin receptor mediates apparent autocrine regulation of leptin gene expression
196. Positional cloning of the mouse obese gene and its human homologue
197. The role of angiotensin II and its receptors in regulation of adipose tissue metabolism and cellularity
198. Tumor necrosis factor increases serum leptin levels in humans